Tag: ElMindA

OurCrowd’s portfolio company ElMindA featured in the Times of Israel

OurCrowd portfolio company ElMindA was featured in The Times of Israel, an English-language news website covering Israel, the region & the Jewish world. ElMindA is the world’s first FDA-cleared neuronal functional assessment tool. ElMindA’s solution uniquely measures how different parts of the brain communicate by uploading measured neural activity into the cloud where proprietary algorithms map out neural association. Fresh from its recent award as one of the 49 most innovative startups in the world by the World Economic Forum, Israeli biotechnology firm ElMindA, developers of the world’s first FDA-approved neural functional assessment tool to visualize serious brain trauma and illnesses, announced last week that it had received $28 million in a Series C financing round. ElMindA had to turn away investors anxious to put their money into what could be the next big Israeli med tech exit, according to investment experts familiar with the firm. ElMindA raised $2,282,318 from OurCrowd investors in July 2015. Read more on The Times of...

Read More

OurCrowd’s portfolio company ElMindA featured in the Times of Israel

OurCrowd portfolio company ElMindA was featured in The Times of Israel, an English-language news website covering Israel, the region & the Jewish world. ElMindA is the world’s first FDA-cleared neuronal functional assessment tool. ElMindA’s solution uniquely measures how different parts of the brain communicate by uploading measured neural activity into the cloud where proprietary algorithms map out neural association. Israeli biotechnology firm ElMindA – developers of the world’s first FDA-approved neural functional assessment tool to visualize serious brain trauma and illnesses – has been named one of the 49 most innovative start-ups in the world by the World Economic Forum. While most brain monitoring systems require the invasive insertion of a sensor inside the head, ElMindA’s BNA takes its measurements using a sensor-laden futuristic looking “helmet” that contains dozens of electrodes to measure activity through the skull. The sensors are able to measure the electronic activity of the brain at different points, with each sensor recording the activity associated with a specific brain function – thought, memory, activity, etc. . ElMindA raised $2,282,318 from OurCrowd investors in July 2015. Read more on The Times of...

Read More

And The Winner Is… | Notable awards received by OurCrowd’s portfolio companies

Over the last few months, OurCrowd’s portfolio companies have received several awards in various competitions recognizing their innovative achievements in their respective fields and in the broader startup ecosystem (such as the 9 companies who won The Red Herring Top 100 award this April). Here is a quick recap of some of our companies’ recent notable awards: ElMindA and Consumer Physics named by the WEF “Technology Pioneers 2015” Consumer Physics and ElMindA were two of the 49 companies from 10 countries selected by the World Economic Forum as the Technology Pioneers of 2015. The World Economic Forum’s annual Technology Pioneers program recognizes early-stage companies from around the world that are involved in the design, development and deployment of new technologies, and are poised to have a significant impact on business and society. Consumer Physics and ElMindA were selected from among hundreds of applicants by a selection committee of 68 academics, entrepreneurs, venture capitalists and corporate executives. Nativeflow Named a 2015 “Cool Vendor” in Mobile Security and IoT Security by Gartner Nativeflow has been recognized for its innovative dynamic wrapping technology as a Cool Vendor in...

Read More

This week on OurCrowd’s QuickFire webinar: Mark One, Influitive, and ElMindA

Check it out: May was one of OurCrowd’s most active months to date for investment opportunities. As part of OurCrowd’s new QuickFire webinar series, we presented three of our latest investment opportunities — Mark One (lifestyle tech), Influitive (advocate marketing), and ElMindA (brain mapping) — in order to allow investors to get to know the companies, hear updates, and meet their platforms. View the webinar recording below or online here. QuickFire Webinar: A Chance to Meet 3 Companies in 1 Hour (6/3/15) The next QuickFire webinar will be held later this month, for information and updates on the time and date email us at webinar@ourcrowd.com. To find out more about these investment opportunities and others on our investment platform, click here. ——— [xyz-ihs...

Read More

What We’re Investing In: Current investment opportunities on OurCrowd (April 2015)

Diversification is one of the most basic and important principals of investing.  This April, we launched a broad range of companies across a multitude of industries on OurCrowd’s platform. These span from cutting-edge brain technology to the world’s first meter-dosed medical cannabis inhaler. For more information on all of our currently funding companies, visit the site and click the “Browse Startups” tab. Below, read about five of the companies we’re investing in this April on OurCrowd; for an under-the-radar investment, log in on www.ourcrowd.com. Syqe Medical Syqe Medical is the world’s first meter-dosed, medical cannabis inhaler. Today, doctors have no way to measure the intake of prescription cannabis to patients, which directly impacts the affectivity of the prescription. Syqe is getting in at the ground floor of what is projected to be an $11B legal cannabis market in the US alone. Perry Davidson, founder and CEO of Syqe, has over 9 years of experience in controlled substance regulation and state implementation in Israel. Click here to learn more about Syqe ElMindA Over 2 billion people worldwide live with some form of...

Read More

Latest from Twitter